Topical pimecrolimus does not prolong clear graft survival in a rat keratoplasty model

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 11, 2007, Pages 1717-1721

  Birnbaum, Florian ^a   Schwartzkopff, Johannes ^a   Scholz, Christoph ^a   Reinhard, Thomas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Immunosuppression; Keratoplasty; Pimecrolimus

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DONOR; DRUG EFFICACY; EDEMA; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KERATOPLASTY; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; VASCULARIZATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGENS, CD; CORNEA; DISEASE MODELS, ANIMAL; FEMALE; GRAFT SURVIVAL; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; RATS; RATS, INBRED F344; RATS, INBRED LEW; TACROLIMUS;

EID: 34848861373     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0657-7     Document Type: Article

References (15)

1. Birnbaum F, Böhringer D, Sokolovska Y et al (2005) Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: A retrospective study. Transplantation 79:964-968
2. Birnbaum F, Reis A, Reinhard T (2007) Immunosuppression following penetrating keratoplasty. Ophthalmologe 104:371-372
3. Birnbaum F, Reis A, Reinhard T (2007) Topical immunosuppressives after penetrating keratoplasty. Ophthalmologe 104:381-387
4. Gisondi P, Ellis CN, Girolomoni G (2005) Pimecrolimus in dermatology: atopic dermatitis and beyond. Int J Clin Pract 59:969-974
5. Herbort CP, Matsubara M, Nishi M et al (1989) Penetrating keratoplasty in the rat: A model for the study of immunosuppressive treatment of graft rejection. Jpn J Ophthalmol 33:212-220
6. Hikita N, Lopez JS, Chan CC et al (1997) Use of topical FK506 in a corneal graft rejection model in Lewis rats. Invest Ophthalmol Vis Sci 38:901-909
7. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
8. Ling M, Gottlieb A, Pariser D et al (2005) A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. J Dermatol Treat 16:142-148
9. Mayer K, Birnbaum F, Reinhard T et al (2004) FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations. Br J Ophthalmol 88:915-919
10. Nell B, Walde I, Billich A et al (2005) The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: Results from an exploratory study. Vet Ophthalmol 8:39-46
11. Reinhard T, Mayweg S, Reis A et al (2005) Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study. Transpl Int 18:193-197
12. Reinhard T, Reis A, Mayweg S et al (2002) Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study. Klin Monatsbl Augenheilkd 219:125-131
13. Reis A, Birnbaum F, Reinhard T (2007) Systemic immunosuppressives after penetrating keratoplasty. Ophthalmologe 104:373-380
14. Reis A, Megahed M, Reinhard T et al (2000) Coadministration of the new macrolide immunosuppressant RAD and mycophenolate mofetil in experimental corneal transplantation. Transplantation 70:1397-1401
15. Reis A, Reinhard T, Sundmacher R et al (1998) Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model. Br J Ophthalmol 82:700-703